Trial intelligence / Profile preview

ROTEM vs Standard Care in Massive Obstetric Hemorrhage

NCT03784794Completed

Start
Nov 2018
Primary completion
Nov 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of Fibrinogen human and prothrombin complex concentrate, human in postpartum hemorrhage (PPH) (2 arms). Primary endpoint: Number of allogeneic blood products transfused. Started Nov 2018; status: completed.

02

Drugs

Fibrinogen humanprothrombin complex concentrate, human
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT03784794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03784794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call